Skip Nav Destination
1-20 of 33
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Margaret Guy, MD, Lauren Magee, PharmD, BCPS, Jessica Keiser, MD, Nicole Carter, RN, MSN, NP-C, DaleMarie Vaughan, PharmD, BCPS, Chantal McHenry, BS, Daniel Sop, BS,MS, Sarah Hartigan, MD, Wally R Smith, MD
Blood (2019) 134 (Supplement_1): 3446.
Proton Pump Inhibitors Associated with Higher Incidence of Mucositis in Patients Receiving Methotrexate for Graft Vs Host Disease Prophylaxis
Luke Mountjoy, DO, Daniel Almquist, MD, Henry Ofori, Pharm D, RPh, Marlene Girardo, MS, Margaret McCallen, Pharm D, RPh
Blood (2019) 134 (Supplement_1): 3262.
Blood (2019) 134 (Supplement_1): 3383.
Angie Mae Rodday, PhD, Kimberly S Esham, MD, Nicole S Savidge, BA, Daqin Mao, PhD, Ruth Ann Weidner, MBA, MRP, Susan K Parsons, MD MRP
Blood (2018) 132 (Supplement 1): 5884.
Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD
Blood (2018) 132 (Supplement 1): 4699.
Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis in Myeloablative Allogeneic Hematopoietic Transplantation Shortens the Duration of Mucositis and Hospitalization
Craig W. Freyer, PharmD, Alex Ganetsky, PharmD, Colleen Timlin, PharmD, Daria V. Babushok, MD PhD, Noelle V. Frey, MD, Saar I. Gill, MD PhD, Elizabeth O. Hexner, MD MS, Alison W. Loren, MD MS, James K. Mangan, MD PhD, Mary Ellen Martin, MD, Shannon R. McCurdy, MD, Alexander E. Perl, MD, Selina Luger, MD, Jacqueline Smith, MSN, CRNP, Edward Stadtmauer, David L. Porter, MD
Blood (2018) 132 (Supplement 1): 5696.
Pharmacokinetics and Toxicities after Evomela® (propylene glycol free melphalan) with Autologous Hematopoietic Stem Cell Transplant (AHCT) for Multiple Myeloma and AL Amyloidosis
Gunjan L. Shah, MD, Heather Landau, MD, Caitlin Sarubbi, A.B, Ryan Schofield, MS, Andrew Lin, PharmD, Valkal Bhatt, PharmD, Stephen J. Harnicar, PharmD, Sean M. Devlin, PhD, David J. Chung, MDPhD, Parastoo B. Dahi, MD, Guenther Koehne, MDPhD, Roni Tamari, MD, Dean Carlow, MDPhD, Sergio A. Giralt, MD
Blood (2017) 130 (Supplement 1): 3296.
Understanding Sleep in Pediatric Patients with Sickle Cell Disease Admitted for Vaso-Occlusive Pain Crisis through Objective Data
Blood (2017) 130 (Supplement 1): 4791.
Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)
Gunjan L. Shah, MD, Andrew Lin, PharmD, Ryan Schofield, MS, Caitlin Sarubbi, AB, Elaina V. Preston, PA-C,MPH, Sean M. Devlin, PhD, Valkal Bhatt, PharmD, Stephen J. Harnicar, PharmD, Elizabeth Hoover, BS, David J. Chung, MDPhD, Parastoo B. Dahi, MD, Guenther Koehne, MDPhD, Roni Tamari, MD, Dean Carlow, MDPhD, Sergio A. Giralt, MD, Heather Landau, MD
Blood (2017) 130 (Supplement 1): 2023.
Targeted Inhibition of Activated Protein C Anticoagulant Activity By Monoclonal Antibody HAPC1573 for Treatment of Hemophilia
Xiao-Yan Zhao, PhD, Subramanian Yegneswaran, PhD, Maxine Bauzon, Derek Sim, Chandra Patel, PhD, Doug Schneider, Kirk McLean, Ying Zhu, MD, Xiaoqiao Jiang, Vince Evans, Jian-Ming Gu, PhD, Inge Ivens, PhD, Jun Xu, PhD, Peter Wolfgang Bringmann, PhD, Katalin Kauser, Charles Esmon, PhD
Blood (2016) 128 (22): 80.
Paul S Martin, MD, Elahe Mostaghel, MD PhD, Stephen Mongovin, Shani L. Frayo, Ailin Zhang, Kerstin Lara Edlefsen, MD, Oliver W Press, MD PhD, Ajay K. Gopal, MD
Blood (2016) 128 (22): 3014.
Benefits of Patient-Controlled Analgesia without Continuous Infusion for the Treatment of Sickle Cell Disease Vaso-Occlusive Crisis Pain
Veronica Carullo, MD, Meagan Murphy, PNP, Jaeun Choi, PhD, Qi Gao, PhD, Catherine Driscoll, MD, Deepa Manwani, MD
Blood (2015) 126 (23): 3398.
Opioid Prescription Practices at Discharge and 30-Day Returns in Children with Sickle Cell Disease and Pain
Blood (2015) 126 (23): 3417.
Lower Continuous Infusion, Higher Bolus Dose Patient-Controlled Analgesia Results in Shorter Hospitalization in Children with Sickle Cell Vaso-Occlusive Pain Crisis
Blood (2015) 126 (23): 523.
Amifostine Reduces High-Dose Melphalan Induced Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplant (HCT) for Plasma Cell Myeloma
Vinita Gupta, MD, Hulya Armutlugoynuk, MD, Anant Vatsayan, MD MBBS, Paolo F. Caimi, MD, Brenda Cooper, MD, Leland Metheny, MD, Ehsan Malek, MD, Erica L. Campagnaro, MD, Stan Gerson, MD, Marcos de Lima, MD, Hillard M. Lazarus, MD, Richard J Creger, PharmD
Blood (2015) 126 (23): 5491.
Emergency Department Physicians Management Versus Hospitalists Service Management Admittance Rates for Sickle Cell Disease Patients from an Emergency Department Observation Unit
Taylor Mueller, BS, LaShon Sturgis, MD PhD, Patrick Loeffler, BS, Ann-Marie Kuckinski, PhD, Abdullah Kutlar, MD, Robert Gibson, PhD, Matthew Lyon, MD
Blood (2015) 126 (23): 5568.
Implementation of a Community Hospital-Based Fast Track Pathway for the Treatment of Acute Pain Episodes in Adults with Sickle Cell Disease
Richard Lottenberg, MD, Robert Krywicki, MD, Gurinder Doad, MD, Witemba Kabange, MD, Monisola Modupe, MD, Gregory Steele, APRN, Zerettia K McGriff, RN,BS, James A Sirleaf, MD, Abdullah Kutlar, MD, Robert Gibson, PhD, Betsy Clair, Matthew L Lyon, MD
Blood (2014) 124 (21): 4854.
Thomas Sinegre, PharmD, Armand Abergel, MD, PhD, Géraldine Lamblin, MD, Marc G Berger, MD, PhD, Aurélien Lebreton, MD, PhD
Blood (2013) 122 (21): 2361.
Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease
Laura M. De Castro, MD, Ted Wun, MD, Sophie Lanzkron, MD MHS, Wally R. Smith, MD, Kathryn L. Hassell, MD, Abdullah Kutlar, MD, Kim Smith-Whitley, MD, Seungshin Rhee, MS, Marilyn J. Telen, MD, Helen Thackray, MD
Blood (2013) 122 (21): 775.
Caitlin M. Neri, M.D., M.P.H. Candidate, Sophie Pestieau, M.D., Heather Young, Ph.D., M.P.H., C.H.E.S., Angelo Elmi, Ph.D., Deepika S. Darbari, M.D.
Blood (2012) 120 (21): 3226.